Halloween has taken over Roblox for the past three weeks, and as the day finally approaches, it's no surprise that the celebrations are continuing across the weekend. But this week, it's not just ...

The rallies unleashed by Argentina President Javier Milei’s surprising electoral win were stunning, with bond prices posting record gains and the stock market skyrocketing over 20% as investors ...

HBO's hit teen drama Euphoria Season 3 has been the talk of the town ever since the show was renewed earlier this year in February after a long hiatus following the second chapter. With solid RT ...

Roblox CEO and co-founder, Dave Baszucki, says "safety is a top priority," despite a civil lawsuit and a Middle Eastern country's banishment of the online gaming platform. During an interview with FOX ...

Games Louisiana sues Roblox over child safety concerns: 'It's basically open season for sex predators on this platform' Games Kentucky sues Roblox, calling it 'a playground for predators who seek to ...

With Season 3 of Euphoria finally in production after more than three years, creator Sam Levinson apparently isn’t taking any chances with spoilers. Jacob Elordi, who reprises his role as Nate Jacobs ...

Oct 22 (Reuters) - Beyond Meat's (BYND.O), opens new tab highly shorted shares jumped more than 60% on Wednesday, fueled by a fresh wave of buying among retail traders who have sparked meme stock ...

A DeKalb County family filed a federal lawsuit against Roblox and Discord, claiming their now 14-year-old son was groomed by a predator who convinced him to send explicit photos. The family’s attorney ...

ORLANDO, Fla. – Allegations of child exploitation and grooming on Roblox have sparked legal action and a criminal investigation in Florida. On Monday, the state announced it is targeting the popular ...

Florida Attorney General James Uthmeier is accusing the popular online gaming platform Roblox of becoming "breeding grounds for predators" and is issuing criminal subpoenas against the company on ...

Neuphoria Therapeutics’ lead candidate has failed to improve social anxiety symptoms in a late-stage trial, prompting the biotech to discontinue the program and launch a strategic review of its ...